Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results
搜索文档
Cynata Therapeutics Limited (CYYNF) Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results - Slideshow (OTCMKTS:CYYNF) 2026-06-24
Seeking Alpha· 2026-06-25 07:06
新闻内容技术访问问题 - 为确保正常访问未来不再出现技术阻碍，需在浏览器中启用Javascript和cookies功能 [1] - 若用户启用了广告拦截器，可能导致访问流程被阻断，需禁用广告拦截器并刷新页面以继续 [1]
